Jiabin Xu Selected Research

Jiabin Xu Research Topics

7	Neoplasms (Cancer) 11/2023 - 01/2019
3	Hepatocellular Carcinoma (Hepatoma) 07/2023 - 01/2020
2	Myocardial Infarction 01/2023 - 10/2022
2	COVID-19 01/2023 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 01/2021
2	Triple Negative Breast Neoplasms 01/2020 - 01/2019
1	Intervertebral Disc Degeneration 01/2024
1	Cardiogenic Shock 01/2023
1	Squamous Cell Carcinoma of Head and Neck 01/2023
1	Infections 01/2023
1	Atrial Fibrillation 10/2022
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2022
1	Mycoses (Diseases, Fungus) 04/2021
1	Inflammation (Inflammations) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Fibrosis (Cirrhosis) 12/2014

5	Clofazimine (Lamprene)FDA Link 11/2023 - 01/2019
3	Long Noncoding RNAIBA 07/2023 - 01/2021
2	VaccinesIBA 01/2023 - 07/2022
2	Antisense RNA (Anti-Sense RNA)IBA 05/2022 - 01/2021
2	MicroRNAs (MicroRNA)IBA 05/2022 - 01/2021
1	ginsenoside Rg3IBA 01/2024
1	HydrogelsIBA 07/2023
1	N-methyladenosineIBA 07/2023
1	bis-methylsulfate 1,1'- dimethyl- 2,2'- dicyano- 4,4'- bipyridiniumIBA 01/2023
1	NanovaccinesIBA 01/2023
1	CateninsIBA 01/2023
1	Nucleic AcidsIBA 07/2022
1	Proteins (Proteins, Gene)FDA Link 07/2022
1	3' Untranslated Regions (3' UTR)IBA 01/2022
1	AminesIBA 10/2021
1	A 7 (A-7)IBA 10/2021
1	PesticidesIBA 04/2021
1	famoxadoneIBA 04/2021
1	Competitive Endogenous RNAIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Interleukin-33IBA 12/2014

5	Therapeutics 01/2023 - 01/2019
2	Drug Therapy (Chemotherapy) 07/2023 - 01/2019
2	Immunotherapy 01/2023 - 07/2022
1	Injections 07/2023
1	Percutaneous Coronary Intervention 01/2023
1	Critical Care (Surgical Intensive Care) 01/2023
1	Counterpulsation (External Counterpulsation) 01/2023
1	Catheter Ablation 10/2022